Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

l2007s

Rank: President [?]

Points: 18410 [?]

Votes: 123 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

PDSG

posted on Oct 17, 2011 05:42PM

Our Wholly-Owned Subsidiary Cannot Operate Without Our Continued Support.

Since the acquisition of our wholly-owned subsidiary PDSG in September 2008, we have provided 100% of PDSG’s operational funding amounting to approximately $8,550,000 through August 31, 2011. After restructuring measures initiated in October 2009 and continued through August 31, 2011, PDSG continues to remain unable to generate sufficient revenues to support its operations and remains entirely dependent on our funding. During October 2011, PTSC retained the services of an investment banker to seek a buyer for PDSG. Should a sale of PDSG occur, it may be on distressed terms with only minimal consideration realized.